Magnetic Resonance Imaging-guided Adaptive Radiotherapy for Urological Cancers: What Urologists Should Know

Linda G W Kerkmeijer; Amar U Kishan; Alison C Tree

doi:10.1016/j.eururo.2021.12.019

Magnetic Resonance Imaging-guided Adaptive Radiotherapy for Urological Cancers: What Urologists Should Know

Eur Urol. 2022 Aug;82(2):149-151. doi: 10.1016/j.eururo.2021.12.019. Epub 2022 Jan 11.

Authors

Linda G W Kerkmeijer¹, Amar U Kishan², Alison C Tree³

Affiliations

¹ Radiation Oncology, Radboud University Medical Center, Nijmegen, The Netherlands. Electronic address: linda.kerkmeijer@radboudumc.nl.
² Radiation Oncology, University of California-Los Angeles, Los Angeles, CA, USA.
³ Uro-Oncology, The Royal Marsden Hospital and the Institute of Cancer Research, London, UK.

PMID: 35031164
DOI: 10.1016/j.eururo.2021.12.019

Abstract

Magnetic resonance imaging (MRI)-guided radiotherapy allows for online adaptation of the radiation plan on the basis of anatomical and functional changes during treatment. MRI-guided radiotherapy holds significant promise for broadening the therapeutic window for multiple urological cancers.

Publication types

Editorial
Research Support, Non-U.S. Gov't

MeSH terms

Humans
Magnetic Resonance Imaging / methods
Radiotherapy Dosage
Radiotherapy Planning, Computer-Assisted / methods
Radiotherapy, Image-Guided* / methods
Urologic Neoplasms* / diagnostic imaging
Urologic Neoplasms* / radiotherapy
Urologists

Abstract

Publication types

MeSH terms

Grants and funding